128 related articles for article (PubMed ID: 9132858)
1. [Clinico-morphologic reconsideration of anaplastic lymphoma. Retrospective study of 60 patients with aggressive clinical course and multiple recurrences].
Ageitos AG; Rivas C; Lobo F; Obeso G; Marcos B; Gonzalo I; Echezarreta G; Delgado RG; Oliva H
Rev Clin Esp; 1996 Dec; 196(12):821-7. PubMed ID: 9132858
[TBL] [Abstract][Full Text] [Related]
2. [Expression of latent membrane protein (LMP) in large-cell anaplastic lymphomas].
Gonzalo I; Santón A; Manzanal A; Marcos B; Ageitos A; Bellas C; Rivas C
Sangre (Barc); 1995 Aug; 40(4):289-92. PubMed ID: 7482117
[TBL] [Abstract][Full Text] [Related]
3. [Dipeptidyl aminopeptidase-IV as a histochemical marker of differential diagnosis of large cell anaplastic CD30+-lymphoma and Hodgkin's disease].
Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Pavlovskaia AI; Tupitsyn NN; Sholokhova EN
Arkh Patol; 2000; 62(4):3-8. PubMed ID: 10971865
[TBL] [Abstract][Full Text] [Related]
4. Value of fine-needle aspiration cytology in diagnosis of Hodgkin's lymphoma and anaplastic large cell lymphoma: one centre experience.
Kolonić SO; Prasek-Kudrna K; Roso V; Radić-Kristo D; Planinc-Peraica A; Dzebro S; Kardum-Skelin I; Jaksić B
Coll Antropol; 2010 Mar; 34(1):75-9. PubMed ID: 20432736
[TBL] [Abstract][Full Text] [Related]
5. [Large-cell anaplastic lymphomas: a genetic and immunophenotypic study].
Martínez B; Gonzalo I; Robledo M; Benítez J; Ageitos A; Marcos B; Echezarreta G; Sanz C; Rivas C
Sangre (Barc); 1995 Aug; 40(4):293-9. PubMed ID: 7482118
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of therapy of different variants of anaplastic large T-cell lymphomas].
Vinogradova IuE; Lutsenko IN; Kaplanskaia IB; Vorob'ev IA; Samoĭlova RS; Gorgidze LA; Ryzhikova NA; Valiev TT; Giliazitdinova EA; Dzhulakian UL; Egorova EK; Zvonkov EE; Krasil'nikova BB; Magomedova AU; Margolin OV; Mar'in DS; Kremenetskaia AM; Kravchenko SK; Vorob'ev AI
Ter Arkh; 2008; 80(7):33-7. PubMed ID: 18763592
[TBL] [Abstract][Full Text] [Related]
7. [Anaplastic large cell lymphoma based on our clinicopathological cases].
Iványi JL; Marton E; Szabó F; Mahunka M; Kelényi G
Orv Hetil; 1997 Mar; 138(13):779-84. PubMed ID: 9173373
[TBL] [Abstract][Full Text] [Related]
8. The interface of Hodgkin's disease and anaplastic large cell lymphoma.
Chittal SM; Delsol G
Cancer Surv; 1997; 30():87-105. PubMed ID: 9547988
[TBL] [Abstract][Full Text] [Related]
9. Detection of a subset of CD30+ anaplastic large cell lymphoma by interphase fluorescence in situ hybridization.
Shin HJ; Thorson P; Gu J; Katz RL
Diagn Cytopathol; 2003 Aug; 29(2):61-6. PubMed ID: 12889041
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic molecule expression is predictive of prognosis in Hodgkin's-like anaplastic large cell lymphoma.
Asano N; Suzuki R; Matsuo K; Kagami Y; Ishida F; Tamaru JI; Jin GS; Sato Y; Shimoyama Y; Yoshino T; Morishima Y; Nakamura S
Histopathology; 2007 May; 50(6):705-15. PubMed ID: 17493234
[TBL] [Abstract][Full Text] [Related]
11. A single-centre study of treatment outcomes and survival in 120 patients with peripheral T-cell non-Hodgkin's lymphoma.
Pellatt J; Sweetenham J; Pickering RM; Brown L; Wilkins B
Ann Hematol; 2002 May; 81(5):267-72. PubMed ID: 12029536
[TBL] [Abstract][Full Text] [Related]
12. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
13. [Expression and clinical significance of Mcl-1 in T-cell non-Hodgkin's lymphoma].
Lin XB; Jiang WQ; Zhong XY; Luo RZ
Ai Zheng; 2007 Apr; 26(4):435-9. PubMed ID: 17430669
[TBL] [Abstract][Full Text] [Related]
14. Clinical features of CD30 (Ki-1) positive anaplastic large-cell lymphoma (ALCL). Review of the literature.
de Kan R; van 't Veer MB
Neth J Med; 1993 Dec; 43(5-6):277-84. PubMed ID: 8107936
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow examination has limited value in the staging of patients with an anaplastic large cell lymphoma first presenting in the skin. Retrospective analysis of 107 patients.
Benner MF; Willemze R
Br J Dermatol; 2008 Nov; 159(5):1148-51. PubMed ID: 18782320
[TBL] [Abstract][Full Text] [Related]
16. The distinction of Hodgkin's disease from anaplastic large cell lymphoma.
Frizzera G
Semin Diagn Pathol; 1992 Nov; 9(4):291-6. PubMed ID: 1480851
[TBL] [Abstract][Full Text] [Related]
17. Clinical spectrum of primary cutaneous CD30-positive anaplastic large cell lymphoma: an analysis of the Mannheim Cutaneous Lymphoma Registry.
Booken N; Goerdt S; Klemke CD
J Dtsch Dermatol Ges; 2012 May; 10(5):331-9. PubMed ID: 22525148
[TBL] [Abstract][Full Text] [Related]
18. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
19. CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis.
Gorczyca W; Tsang P; Liu Z; Wu CD; Dong HY; Goldstein M; Cohen P; Gangi M; Weisberger J
Int J Oncol; 2003 Feb; 22(2):319-24. PubMed ID: 12527929
[TBL] [Abstract][Full Text] [Related]
20. Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology.
Jaffe ES
Mod Pathol; 2001 Mar; 14(3):219-28. PubMed ID: 11266530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
